FRA:GIN • CH0010645932
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GIVAUDAN-REG (GIN.DE).
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.117B 6.48% | 6.915B -2.84% | 7.412B 7.19% | 7.661B 3.36% | 7.91B 3.25% | 8.294B 4.85% | 8.939B 7.78% | 9.333B 4.41% | 9.805B 5.06% | 9.672B -1.36% | 9.947B 2.84% | |
| EBITDA YoY % growth | 1.467B -1.81% | 1.476B 0.61% | 1.764B 19.51% | 1.864B 5.67% | 1.928B 3.43% | 2.017B 4.62% | 2.128B 5.50% | 2.214B 4.04% | 2.3B 3.88% | N/A | N/A | |
| EBIT YoY % growth | 1.103B -0.09% | 1.12B 1.54% | 1.405B 25.45% | 1.491B 6.12% | 1.557B 4.43% | 1.644B 5.59% | 1.689B 2.74% | 1.77B 4.80% | 1.802B 1.81% | 1.775B -1.50% | 1.816B 2.31% | |
| Operating Margin | 15.50% | 16.20% | 18.96% | 19.46% | 19.68% | 19.82% | 18.89% | 18.96% | 18.38% | 18.35% | 18.26% | |
| EPS YoY % growth | 92.71 2.18% | 104.84 13.08% | 124.48 18.74% | 128.65 3.35% | 132.93 3.32% | 141.18 6.21% | 151.58 7.37% | 154.49 1.92% | 162.38 5.11% | N/A | N/A |
All data in CHF
| Q4 / 25 | Q2 / 26 | Q4 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | 60.24 3.76% | 68.49 2.41% | 65.50 8.74% |
| Revenue Q2Q % growth | 3.717B 1.14% | 3.992B 3.31% | 3.992B 7.40% |
| EBITDA Q2Q % growth | 879.1M -14.40% | 998.94M 6.04% | 969.39M 10.27% |
| EBIT Q2Q % growth | 707.84M 5.96% | 809.22M 6.62% | 779.82M 10.17% |
All data in CHF
28 analysts have analysed GIN.DE and the average price target is 4402.24 EUR. This implies a price increase of 29.36% is expected in the next year compared to the current price of 3403.
GIVAUDAN-REG (GIN.DE) will report earnings on 2026-04-14.
The consensus EPS estimate for the next earnings of GIVAUDAN-REG (GIN.DE) is 60.24 EUR and the consensus revenue estimate is 3.72B EUR.
The expected long term growth rate for GIVAUDAN-REG (GIN.DE) is 3.19%.